Tag: Drug discovery

Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition

businessnewstoday- May 4, 2021 0

Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma ... Read More

Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership

businessnewstoday- March 23, 2021 0

AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing ... Read More

Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities

businessnewstoday- February 26, 2021 0

Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More

PostEra, Pfizer partner to advance machine learning for drug discovery

pharmanewsdaily- December 7, 2020 0

PostEra, a biotech company specializing in machine learning solutions for preclinical drug discovery, has forged a partnership with Pfizer for speeding up the discovery of ... Read More

PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor

pharmanewsdaily- December 6, 2020 0

PharmaEngine has signed a collaboration and license deal with UK-based Sentinel Oncology for advancing the new drug development of SOL-578, a checkpoint kinase 1 inhibitor ... Read More

PerkinElmer to acquire cell engineering company Horizon Discovery

pharmanewsdaily- November 3, 2020 0

US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to ... Read More

Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

pharmanewsdaily- August 11, 2020 0

US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in ... Read More

Curi Bio acquires Dana Solutions to boost drug discovery platforms

pharmanewsdaily- July 25, 2020 0

Curi Bio, a developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a provider of artificial intelligence and machine learning technologies for ... Read More

Cyclica, Genome Institute of Singapore sign drug discovery partnership

pharmanewsdaily- April 14, 2020 0

Canadian biotech company Cyclica has signed a multi-year and multi-project drug discovery partnership with the Genome Institute of Singapore (GIS) in oncology and related diseases. ... Read More

Gilead Sciences, Second Genome form IBD drug discovery alliance

pharmanewsdaily- April 9, 2020 0

Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second Genome to discover targets and drug candidates ... Read More